CX Institutional’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Sell
91,216
-4,571
-5% -$223K 0.14% 154
2026
Q1
$4.11M Buy
+95,787
New +$4.12M 0.13% 178
2019
Q3
Sell
-103
Closed -$2K 840
2019
Q2
$2K Buy
+103
New +$2.16K ﹤0.01% 750

Other funds holding EXEL

CX Institutional's EXEL Position: Q2 2026 in Review

CX Institutional reduced its Exelixis (EXEL) stake by 4.8% in Q2 2026, selling an estimated $223K and leaving 91,216 shares worth $4.96M. The position accounts for 0.14% of the portfolio, ranked #154.

CX Institutional first reported a position in EXEL in Q2 2019 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • CX Institutional held 91,216 shares of Exelixis worth $4.96M as of Q2 2026.
  • CX Institutional sold 4,571 Exelixis shares in Q2 2026, an estimated $223K.
  • Exelixis made up 0.14% of CX Institutional's portfolio in Q2 2026, its #154 holding.
  • CX Institutional first reported a position in Exelixis in Q2 2019 and has held it in 3 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.